Navigation Links
Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone-related Assets
Date:7/1/2010

rkets the following brands under co-promotion agreements: AndroGel®, with Solvay Pharmaceuticals, Inc., and Femring®, with Warner Chilcott Limited.  The Watson Brand pipeline portfolio includes a number of products, including URACYST®, under development for cystitis; and four novel new contraceptives.  All other trademarks are property of their respective owners.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement

Statements contained in this press release that refer to non-historical facts are forward-looking statements that reflect Watson's current perspective of existing information as of the date of this release. For example, any statements in this press release concerning the future growth of Watson's product portfolio, the future success of CRINONE® and PROCHIEVE®, the anticipated closing of the acquisition, the anticipated benefits of the acquisition, future approvals or other events related to CRINONE® and PROCHIEVE® and business plans are forward-looking statements. It is important to note that Watson's goals and expectations are not predictions of actual performance. Actual results may differ materially from Watson's current expectations depending upon a number of factors affecting the acquisition or Watson's business. These factors include, among others, the risk of not completing the acquisition for any reason, including as result of third party intervention; successful integration of the Columbia products and product rights; the impact of competitive products and pricing; timel
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 25, 2014  Unilife Corporation (NASDAQ: UNIS, ASX: ... delivery systems, today announced that its Chairman and CEO, ... the Piper Jaffray 26th Annual Healthcare Conference at the ... Tuesday, December 2, 2014. The conference ... "live" listen only Webcast. To listen, please go to: ...
(Date:11/26/2014)... , Nov. 25, 2014 Jazz Pharmaceuticals plc (Nasdaq: ... its corporate presentations at two upcoming investor conferences.  ... UK on Tuesday, December 2, 2014 at 6:45 a.m. ... president and head of EUSA International, will provide an overview of ... th Annual Piper Jaffray Healthcare Conference in New ...
(Date:11/26/2014)... China, Nov. 26, 2014 China Nepstar Chain ... "Company"), a leading retail drugstore chain in China based ... its unaudited financial results for the third quarter ended September ... 30, 2014: , Same store sales increased by ... , Revenue increased by 8.1% to RMB738.3 million (US$120.3 million) ...
Breaking Medicine Technology:Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 11
... , SOUTH SAN FRANCISCO, Calif. , ... biopharmaceutical company focused on innovative oncology therapies, today announced that Ronald ... 12th Annual BIO CEO and Investor Conference on Tuesday, February 9, ... Astoria in New York City . , A live audio ...
... DIEGO , Feb. 5 Volcano Corporation (Nasdaq: ... by Lightlab Imaging, Inc. on January 7, 2009 in ... reached a verdict against Volcano and its wholly owned subsidiary, Axsun ... an agreement to supply tunable lasers to Lightlab for use in ...
Cached Medicine Technology:Poniard Pharmaceuticals to Present at 12th Annual BIO CEO and Investor Conference 2Volcano Corporation Announces Litigation Status 2Volcano Corporation Announces Litigation Status 3
(Date:11/26/2014)... Loffler Companies has been selected as a ... online information and news publication for resellers of imaging ... year Loffler has earned this prestigious award and the ... Awards honor the best and the brightest in the ... were chosen for their innovative marketing and sales programs, ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Senior Planning ... Florida-based SeniorNet, a nonprofit organization providing the adult ... up to help seniors navigate the rough seas of ... on educating seniors on the topic of Medicaid eligibility ... somewhat complicated process of applying for this coverage. ...
(Date:11/26/2014)... NY (PRWEB) November 26, 2014 Call ... research requirements or email the details on sales(at)researchmoz(dot)us ... diabetes and drug discovery market 2014" with deep study ... is the result of high blood sugar. The global ... directly linked to the growing number of diabetics in ...
(Date:11/26/2014)... Baton Rouge, Louisiana (PRWEB) November 26, 2014 ... and neck pain relief and specialists in minimally ... Dr. K. Samer Shamieh into the rapidly growing ... management specialists. The addition coincides with the ... cutting-edge, reliable medical treatment for Louisiana residents who ...
(Date:11/26/2014)... Nov. 25, 2014 (HealthDay News) -- Youngsters who enter ... new study suggests. Early puberty was linked with ... poor self-image and high anxiety levels, according to the ... such as conflict with family and peers, and having ... study found. Although the study found an association ...
Breaking Medicine News(10 mins):Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Louisiana Back Institute Welcomes Dr. K. Samer Shamieh into Medical Provider Network 2Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2
... with material that was learned well, study suggests , , , ... can help boost your memory and remember facts, but only ... new study suggests. , This type of memory is called ... in contrast to "procedural memory," which applies to skills. Sleep ...
... Perrigo Company,(Nasdaq: PRGO ; TASE) today announced ... of $150 million of the Company,s common stock,through ... program. Any,remaining balance of the previously authorized program ... programs since November 2000,Perrigo has repurchased 11.4 million ...
... An anti-virus drug attacks influenza A by changing the motion ... to infect healthy cells, according to a recently published research ... Iowa States John D. Corbett Professor in Chemistry, and Sarah ... of the antiviral drug amantadine on influenza A. Thats the ...
... CDC Director Dr. Ann Albright, WASHINGTON, Feb. 1 , WHAT: ... briefing, "Your Eyes: the Windows to Your Health -- A Briefing ... Eyecare in Prevention," to be presented ... only one-third know they are living ...
... View of LTC Sector Required for Accurate Evaluation of,Seniors, ... on the January,31 New York Times news article reporting ... funding update to help care for the growing,number of ... Alliance for,Quality Nursing Home Care said it will work ...
... is imminent if Propofol coverage isn,t reinstated, NEW ... to,immediately retract its refusal to cover Propofol under all ... Gastroenterologists,and Anesthesiologist Alliance, a call to file a consumer ... once solely a New York State issue has now ...
Cached Medicine News:Health News:A Daytime Nap Can Boost Memory 2Health News:Iowa State chemists track how drug changes, blocks flu virus 2Health News:In Unfolding Budget Debate, Alliance to Spotlight Flawed MedPAC Policy Guidance, Failure to Evaluate Medicaid Margins in Recommending Medicare Funding Levels 2Health News:National Health Care Alliance Gains New Members Against Aetna's New Anesthesia Policy 2Health News:National Health Care Alliance Gains New Members Against Aetna's New Anesthesia Policy 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: